BIOVENTUS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $339.6M | $458.9M | $43.9M |
| FY2022 | $385.0M | $325.2M | $30.2M |
| FY2023 | $367.0M | $173.6M | $37.0M |
| FY2024 | $308.3M | $147.9M | $41.6M |
| FY2025 | $279.0M | $184.1M | $51.2M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $339.6M | $458.9M | $43.9M |
| FY2022 | $385.0M | $325.2M | $30.2M |
| FY2023 | $367.0M | $173.6M | $37.0M |
| FY2024 | $308.3M | $147.9M | $41.6M |
| FY2025 | $279.0M | $184.1M | $51.2M |